All posts tagged
“In the Coming Decade, Off-the-Shelf Cell Therapy will Become a Reality”
Celyad’s Autologous CAR-T Therapy enters Phase Ib
Debunking the Immuno-Oncology Hype: is it as good as it sounds?
The Best Selling Biologic of All Time now chased by New Phase III Biosimilar
Exclusive from BIO-Europe 2015: Interview of Peter Llewellyn-Davies, CFO at Medigene, Munich-based Immunotherapy Biotech
Will Roche lose it’s Worldwide Leading position in Cancer treatments?
Labiotech UG, All Rights Reserved -
Send this to friend